Policy | September 14, 2023
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The hospital hosted a two-day event with top internal and external faculty and medical experts
Ayushman Bhav a comprehensive nationwide healthcare initiative ensures saturation coverage of healthcare schemes, reaching every village and town
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
The brand has launched 6 new range of products to provide a complete pregnancy care solution
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The products will be manufactured at the company's facility in Bengaluru
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
Subscribe To Our Newsletter & Stay Updated
